Antibacterial Potential of Symmetrical Twin-Drug 3,6-Diaminoxanthones

Diana I S P Resende1,2, Fernando Durães1,2, Sidika Zubarioglu1

  • 1Laboratory of Organic and Pharmaceutical Chemistry (LQOF), Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

PubMed

Insights

Researchers developed novel 3,6-disubstituted xanthones to combat multi-drug resistant bacteria by inhibiting efflux pumps. Compound 16 showed significant antibacterial activity against resistant strains, offering a potential new strategy against antimicrobial resistance.

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Global health is threatened by rising infectious diseases and multi-drug resistant pathogens.
  • Antibiotic-resistant bacteria pose a significant challenge, necessitating new antimicrobial targets and chemical entities.
  • Efflux pumps contribute to antimicrobial resistance by expelling drugs from bacterial cells.

Purpose of the Study:

  • To synthesize and develop a library of 3,6-disubstituted xanthones using twin drug and molecular extension strategies.
  • To investigate the potential of these xanthone derivatives in inhibiting bacterial efflux pumps, biofilm formation, and quorum-sensing.
  • To evaluate the in vitro antimicrobial properties and cytotoxicity of the synthesized compounds.

Main Methods:

  • Synthesis of 3,6-diaminoxanthones via reaction of a xanthone precursor with primary and secondary amines.
  • In vitro antimicrobial testing against pathogenic strains, including minimum inhibitory concentration (MIC) determination.
  • Assays for efflux pump inhibition (ethidium bromide accumulation), antibiofilm activity (crystal violet assay), and quorum-sensing inhibition.
  • Cytotoxicity evaluation using mouse fibroblast cell line NIH/3T3.

Main Results:

  • Several synthesized xanthone derivatives demonstrated effective antibacterial properties against Gram-positive bacteria.
  • Xanthone 16 exhibited potent activity against *Staphylococcus aureus* and *Enterococcus faecalis*, including methicillin-resistant strains.
  • Some derivatives showed antibiofilm potential, and others inhibited bacterial efflux pumps.
  • Two hydroxyl-substituted xanthone derivatives displayed no significant cytotoxicity.

Conclusions:

  • The substituent's nature is crucial in determining the antimicrobial spectra of aminated xanthones.
  • The developed 3,6-disubstituted xanthones represent promising candidates for combating antibiotic-resistant bacteria.
  • These compounds offer a potential strategy to overcome bacterial resistance mechanisms, particularly efflux pump activity.